Tracking the PMCB option chain helps you see every strike and expiry on PharmaCyte Biotech Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. PharmaCyte Biotech Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PMCB options activity at a glance. Use our scanner to monitor the PMCB option chain in real time and filter for the PMCB options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PMCB stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PMCB option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PMCB stock options are being actively traded and where they are not.
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant.
It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls PharmaCyte Biotech Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen PMCB options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PMCB stock options — let the full option chain come to you, pre-filtered and ready to trade.
